Currently, many researchers have proved that the status of TP53 gene is closely related to the prognosis of BC (45, 46), but it could not improve the prognostic accuracy in the absence of comprehensive bioinformatics and clinicopathological factors analysis. This evidence concerns the gene TP53 and breast cancer.